Bind Therapeutics amends IPO

Bind Therapeutics Inc., Cambridge, Mass. Business: Cancer, Drug delivery Date announced: 9/5/13 Type: IPO To be raised: Up to $86.5 million Shares: 4.7 million Price: $14-$16 Underwriters: Credit Suis...